Pacira BioSciences, Inc.
Shawn Cross (Chief Financial Officer) reports PCRX insider transactions
About this filing
Pacira BioSciences, Inc. (PCRX) filed Form 4 (insider transaction) with the SEC on Nov 3, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Shawn Cross · Chief Financial Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | F · tax withholdingFootnotes F1 | −9,540 | $36.39 | $347,160.60 | 95,801 | Direct |
Footnotes
- F1 Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.
More PCRX filings
- 8-K
Filed Nov 12, 2026
- SC 14D9/A
Filed Nov 12, 2026
- 10-Q
Filed Nov 5, 2026
- 8-K
Filed Nov 5, 2026
- SC 14D9/A
Filed Nov 3, 2026
- SC 13G/A
Filed Oct 30, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.